Dual Inhibition of IGF-IR and ALK as an Effective Strategy to Eradicate NPM-ALK+ T-Cell Lymphoma

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-019-0768-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Significance of NPM-ALK Fusion Transcript Overexpression in ALK-positive Anaplastic Large-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

Enteropathy-Associated Anaplastic Large T Cell Lymphoma ALK-positive (EA-ALCL-ALK+): Variant of T Cell Lymphoma With Possible Two-Hit Pathogenesis

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2013English

ALK-negative Anaplastic Large Cell Lymphoma

2020English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Anaplastic Lymphoma Kinase (ALK)

Science-Business eXchange
2008English

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

Chronic Type Adult T-Cell Leukemia-Lymphoma After Autolougous Stem Cell Transplantation for ALK-negative Anaplastic Large Cell Lymphoma

Retrovirology
VirologyInfectious Diseases
2015English

Anaplastic Large Cell Lymphoma, Alk-Negative: Analysis of 235 Cases Collected by the T-Cell Project

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

ALK Positive Diffuse Large B-Cell Lymphoma, Lymphoplasmablastic Differentiation

Pathology Discovery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy